Clinical trials · New York, NY
Epilepsy clinical trials in New York
We’re tracking 24 recruiting epilepsy studies with a site in or near New York — including Phase 1/Phase 2, Phase 2, Phase 2/Phase 3, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near New York
- NCT06555965Recruiting
STXBP1 and SYNGAP1 natural history study
This study follows people with STXBP1 or SYNGAP1 gene changes over time to learn more about how these conditions affect the body and mind. It does not test a treatment but helps researchers understand the natural course of the disorder.
New York, New YorkAges Any age - NCT07088835Recruiting
Safety study of ear-worn seizure monitor
This study tests a new ear-worn sensor to monitor brain activity. It will see if the device is safe and easy to use for recording seizures. Healthy volunteers and people with suspected seizures are both needed.
New York, New YorkAges 18–70 - NCT03400371Recruiting
Study of brain signals in juvenile myoclonic epilepsy
This study looks at EEG brain recordings in people with juvenile myoclonic epilepsy, especially those whose seizures started between ages 10 and 25. It may help researchers better understand how this epilepsy works and improve future care.
New York, New YorkAges 10–40 - NCT05082181Recruiting
Phone group support for adults with epilepsy and depression
This study tests whether telephone-based group support helps adults with epilepsy who also have elevated depressive symptoms. Sessions are recorded, and you’ll join by phone in English or Spanish.
New York, New YorkAges 18–99 - NCT05135091RecruitingPhase 3
Cell therapy trial for hard-to-control one-sided temporal lobe epilepsy
This Phase 3 study tests a neural cell therapy (NRTX-1001) for adults whose seizures come from one side of the hippocampus and have not improved with standard seizure medicines. The goal is to reduce seizure frequency and improve seizure control where other treatments have not worked.
New York, New YorkAges 18–75 - NCT05085704Recruiting
Brain scans to study metabolism in healthy and diabetic people
This study uses MRI brain scans at different strengths to measure how the brain uses energy (metabolism) in health and in people with genetically confirmed G1D. It may help researchers understand brain energy changes related to metabolic disease and diabetes.
New York, New YorkAges 16–80 - NCT05019885RecruitingPhase 2
IV ketamine for hard-to-treat epilepsy in adults
This Phase 2 study tests whether a low dose of IV ketamine can reduce seizures in adults with drug-resistant epilepsy. It may help people whose seizures continue despite trying at least two appropriate seizure medicines.
New York, New YorkAges 18 years+ - NCT07224191Recruiting
Brain wave study during memory tasks
This trial studies brain waves to learn how memory works. It may help people with epilepsy who have special brain implants, or healthy volunteers.
New York, New YorkAges 18–70 - NCT05718817Enrolling by invitationPhase 3
Long-term study of XEN1101 for people with epilepsy
This study gives XEN1101 in an open-label way (everyone knows they’re getting the drug) to people who finished earlier epilepsy studies. It aims to see how the treatment continues to work and whether it’s safe over the long term.
New York, New YorkAges 12 years+ - NCT07219407RecruitingPhase 2
Long-term safety study of RAP-219 for focal seizures
This study tests the long-term safety and effectiveness of RAP-219, an investigative medication for focal epilepsy. It is for people who already completed an earlier study of RAP-219, have a type of epilepsy that doesn't respond to standard medicines, and use a surgically implanted brain device (RNS system) to help manage seizures.
New York, New YorkAges 18–70 - NCT06443463Enrolling by invitationPhase 2
Long-term safety of BHV-7000 in epilepsy
This study checks the long-term safety of BHV-7000 for people who already completed an earlier trial with this drug. You keep taking the same medicine while doctors watch for any side effects over time.
New York, New YorkAges 18–75 - NCT07287163Enrolling by invitationPhase 3
Long-term study of vormatrigine for epilepsy
This trial is for adults with epilepsy who have already taken vormatrigine in a previous study or through a special access program. It aims to collect ongoing safety and effectiveness information.
New York, New YorkAges 18–85 - NCT06551090Recruiting
Anxiety and memory study for temporal lobe epilepsy patients
This research study looks at how anxiety and memory work in people with temporal lobe epilepsy. It uses brain recordings to better understand these conditions, which might lead to better treatments in the future.
New York, New YorkAges 18–55 - NCT06132893RecruitingPhase 2/Phase 3
Testing BHV-7000 for hard-to-control focal seizures in adults
This study tests a new medicine called BHV-7000 for adults whose focal seizures (starting in one part of the brain) are not controlled by current treatments. The goal is to see if it can reduce seizures safely.
New York, New YorkAges 18–75 - NCT07087821Recruiting
Epilepsy self-management study for depression
This study tests two programs (UPLIFT and PACES) that help people with epilepsy manage depressive symptoms. If you have epilepsy and mild-to-moderate depression, you may be able to join.
New York, New YorkAges 18 years+ - NCT04419272RecruitingPhase 4
Methylphenidate for thinking problems in adults with focal seizures
This trial studies whether methylphenidate (a stimulant medicine) can improve thinking and memory problems related to epilepsy. You may be kept on your usual seizure medicines, and your thinking will be tested over about 16 weeks.
New York, New YorkAges 18 years+ - NCT01662453Recruiting
Study risk factors for sudden unexplained death in epilepsy
This study looks at what factors may be linked to sudden, unexplained death in people with epilepsy. Your family’s willingness to participate matters, because the researchers compare cases of sudden unexplained death to people with epilepsy who have not had it.
New York, New YorkAges Any age - NCT04322734Recruiting
Blood tests study immune and metabolism markers in neurodevelopment
This study looks for biological “signals” in blood—related to the immune system and metabolism—to better understand conditions like autism and other brain or development-related disorders. It may help researchers find markers that could guide future diagnosis or treatment.
Brooklyn, New YorkAges Up to 18 years - NCT07563881RecruitingPhase 3
Testing RAP-219 for Focal Seizure Control in Adults
This study tests whether a new medication called RAP-219 can help adults with focal seizures (seizures that start in one area of the brain) control their seizures better. You would take this medication alongside your current seizure drugs for about 12 weeks.
Hackensack, New JerseyAges 18–75 - NCT06908356RecruitingPhase 2
Testing PRAX-628 for focal or tonic-clonic seizures
This study tests an experimental pill called PRAX-628 for adults whose seizures are not fully controlled by current medications. It aims to see if the drug is safe and effective at reducing seizures.
Hackensack, New JerseyAges 18–75 - NCT07600736RecruitingPhase 2
Safety study of ABS-1230 for children with KCNT1 epilepsy
This trial tests a new drug called ABS-1230 in children and young adults with KCNT1-related epilepsy, a rare genetic form of epilepsy. The study will check if the drug is safe and if it helps reduce seizures.
Hackensack, New JerseyAges 1 month–21 years - NCT06063850RecruitingPhase 1/Phase 2
Gene therapy for adults with hard-to-control epilepsy
This trial tests a one-time gene therapy (AMT-260) for adults whose seizures start in one area of the brain (the temporal lobe) and aren't controlled by medication. The goal is to see if it's safe and reduces seizure frequency.
Hackensack, New JerseyAges 18–75 - NCT00859794Enrolling by invitation
Study brain and movement functions in people with difficult epilepsy
This study looks at how the brain and body coordination work in people with epilepsy whose seizures do not fully respond to seizure medicines. Some participants may be people who are being evaluated for a possible epilepsy surgery because tests suggest they could benefit.
Great Neck, New YorkAges 5 years+ - NCT04715646RecruitingPhase 3
Brivaracetam study for children with hard-to-control seizures
This trial looks at how safe brivaracetam is and how well it can be used in children and teens with certain types of epilepsy that are not well controlled. It may help families who are dealing with frequent focal seizures despite taking seizure medicines.
Hawthorne, New YorkAges 1 month+
Hear when a new Epilepsy trial opens near New York, NY
We’ll email you when one opens near New York, NY — at most once a week, no account needed, unsubscribe anytime.
Epilepsy trials in other cities
Where these studies are running near New York
Institutions with a site for the recruiting epilepsy studies listed above.
- NYU Langone Health · 7 studies
- Northeast Regional Epilepsy Group · 6 studies
- Mount Sinai Health System · 3 studies
- BCHP · 2 studies
- Comprehensive Epilepsy Care Center · 2 studies
- Five Towns Neurology · 2 studies
- Institute of Neurology and Neurosurgery at Saint Barnabas · 2 studies
- Northwell Health · 2 studies
What taking part in a epilepsy study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting epilepsy studies in New York.
Common questions
- Are there epilepsy clinical trials near New York?
- Yes. We're currently tracking 24 recruiting epilepsy studies with a site near New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a epilepsy study near New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site near New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a epilepsy trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New epilepsy studies open near New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.